DERMATOLOGY DIAGNOSTIC DEVICES AND THERAPEUTICS MARKET ANALYSIS

Regional Analysis

Regional Insight of the dermatology diagnostic devices and therapeutics market

Geographically, 33.2 % population of North America have significant skin ailments that deserve medical attention. According to the Journal of the American Academy of Dermatology, around 50 million people were affected with acne in North America in 2010, out of which 85% aged between 12 and 24, accounting to higher ratio in young population. In 2017, Food and Drug Administration (FDA) has approved a new product named Dupixent, which is used to treat atopic dermatitis, expected to propel the market growth in this region. According to a report by European Dermato-Epidemiology, in 2014, approximately 19% of the adults and 14% of children have skin diseases that need to be attended in Europe. This is mainly owing to high prevalence and high awareness of skin ailments, well-organized healthcare services, and reimbursement policies.